(Q46857400)

25 December 2017

title

Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder (English)

1 reference

25 December 2017

0 references

1 reference

2

1 reference

25 December 2017

Ole A. Andreassen

12

1 reference

25 December 2017

Stein Opjordsmoen Ilner

9

object named as

Opjordsmoen S

1 reference

25 December 2017

11

Melle I

1 reference

25 December 2017

8

Friis S

1 reference

25 December 2017

Ringen PA

1

1 reference

25 December 2017

Birkenaes AB

3

1 reference

25 December 2017

Engn J

4

1 reference

25 December 2017

Faerden A

5

1 reference

25 December 2017

Jónsdottir H

6

1 reference

25 December 2017

Nesvåg R

7

1 reference

25 December 2017

Larsen F

10

1 reference

25 December 2017

language of work or name

English

0 references

publication date

10 December 2007

1 reference

25 December 2017

published in

Psychological Medicine

1 reference

25 December 2017

volume

38

1 reference

25 December 2017

issue

9

1 reference

25 December 2017

page(s)

1241-1249

1 reference

25 December 2017

Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P).

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Cannabis use and psychosis: a longitudinal population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

From Kraepelin to Kretschmer leavened by Schneider: thextransition from categories of psychosis to dimensions of variation intrinsic to homo sapiens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

The impact of substance abuse on the course of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Substance abuse in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

A meta-analysis of negative symptoms in dual diagnosis schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Rural and urban differences in patients with a dual diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Burden of general medical conditions among individuals with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Substance misuse in patients with schizophrenia: epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Cannabis use and expression of mania in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Epidemiologic review of marijuana use and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Cannabis use and misuse prevalence among people with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Serious mental illness and tobacco addiction: a model program to address this common but neglected issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Substance misuse and psychiatric comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Alcoholism and drug abuse in three groups--bipolar I, unipolars and their acquaintances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Alcohol consumption and the CAGE test in outpatients with schizophrenia or schizoaffective disorder and in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

7 January 2021

Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

7 January 2021

Schizophrenia and co-occurring substance use disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

7 January 2021

Alcohol use and abuse in schizophrenia. A prospective community study

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

7 January 2021

Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

7 January 2021

Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

7 January 2021

Comorbid substance-use in schizophrenia: relation to positive and negative symptoms

1 reference

https://api.crossref.org/works/10.1017%2FS003329170700236X

7 January 2021

10.1017/S003329170700236X

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18070373

1 reference

25 December 2017